Concourse Financial Group Securities, Inc. Evoke Pharma Inc Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share
Q2 2024 Jul 23, 2024	BUY	$0.43 - $0.62 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$0.59 - $1.07 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$1.05 - $1.39 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.96 - $1.73 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.96 - $1.73 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$1.39 - $2.25 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.89 - $5.75 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.44 - $2.68 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.95 - $3.43 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$2.04 - $10.32 $0 - $0

Others Institutions Holding EVOK

# of Institutions

Shares Held

1.46K

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

1.46K
Shares

$688
0.0% of portfolio

View Full List

About Evoke Pharma Inc

Ticker EVOK
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,343,070
Market Cap $1.57M
Description
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabeti...

More about EVOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account